You have 9 free searches left this month | for more free features.

temozolomide

Showing 1 - 25 of 556

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Temozolomide
  • Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Recurrent Glioblastoma Trial in Beijing (Laser interstitial thermal therapy, Temozolomide)

Active, not recruiting
  • Recurrent Glioblastoma
  • Laser interstitial thermal therapy
  • Temozolomide
  • Beijing, China
    Beijing Tiantan Hospital
Dec 22, 2022

Glioblastoma, IDH-wildtype, MGMT-Methylated Glioblastoma Trial in Padova (Regorafenib, Temozolomide)

Recruiting
  • Glioblastoma, IDH-wildtype
  • MGMT-Methylated Glioblastoma
  • Padova, Italy
    Istituto Oncologico Veneto IRCCS
Oct 18, 2023

Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,

Not yet recruiting
  • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
  • Astrocytoma, Grade III
  • Debio 0123
  • +2 more
  • San Antonio, Texas
  • +1 more
Mar 9, 2023

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Ewing Sarcoma Trial in Beijing (Vincristine, Temozolomide)

Recruiting
  • Ewing Sarcoma
  • Beijing, Beijing, China
    Peking University People's Hospital
Oct 31, 2022

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)

Not yet recruiting
  • Recurrent Extensive Stage Small Cell Lung Carcinoma
  • Hangzhou, China
  • +2 more
Feb 5, 2023

Glioblastoma Multiforme (GBM) Trial in Taoyuan (ADI-PEG20, Temozolomide)

Recruiting
  • Glioblastoma Multiforme (GBM)
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou Branch
Sep 29, 2022

Glioblastoma Trial run by the NCI (drug, biological, other)

Completed
  • Glioblastoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 23, 2022

Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

Recruiting
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
Dec 5, 2022

Recurrent Pituitary Adenomas Trial in New York (Capecitabine, Temozolomide)

Terminated
  • Recurrent Pituitary Adenomas
  • New York, New York
    Weill Cornell Medical College
Jul 15, 2022

Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

Recruiting
  • Anaplastic Oligoastrocytoma
  • Glioblastoma
  • Temozolomide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2022

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • PCI 24781
  • Temozolomide
  • (no location specified)
Jan 24, 2023

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Glioblastoma Trial (Hypofractionated radiotherapy, Conventional radiotherapy, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Hypofractionated radiotherapy
  • +2 more
  • (no location specified)
Jun 27, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Recruiting
  • Locally Advanced Leiomyosarcoma
  • +5 more
  • New York, New York
    Columbia University/Herbert Irving Cancer Center
Jan 4, 2023

Melanoma (Skin) Trial in Philadelphia (sorafenib tosylate, temozolomide)

Completed
  • Melanoma (Skin)
  • sorafenib tosylate
  • temozolomide
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 13, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Glioblastoma Trial in Oklahoma City (OKN 007, Temozolomide, Photon/Proton IMRT)

Recruiting
  • Glioblastoma
  • OKN 007
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center, University of Oklahoma Health Sciences
Jun 17, 2022

Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)

Withdrawn
  • Platinum-Sensitive Biliary Tract Cancer
  • (no location specified)
May 27, 2022

Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 22, 2022

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023